Ahmad Bagheri Moghaddam

Application of methylene blue -vitamin C –N-acetyl cysteine for treatment of critically ill COVID-19 patients, report of a phase-I clinical trial

Daryoush Hamidi Alamdari, Ahmad Bagheri Moghaddam, Shahram Amini et al. · European Journal of Pharmacology · 2020 · 120 citations · Full text

Critical Care Medicine, Long Covid, Phase-i Clinical Trial +6

Molecular and cellular mechanisms of the effects of Propolis in inflammation, oxidative stress and glycemic control in chronic diseases

Naseh Pahlavani, Mahsa Malekahmadi, Safieh Firouzi et al. · Nutrition & Metabolism · 2020 · 95 citations · Full text

Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trial

Najmeh Kaffash Farkhad, Alireza Sedaghat, Hamidreza Reihani et al. · Stem Cell Research & Therapy · 2022 · 57 citations · Full text

Effects of propolis and melatonin on oxidative stress, inflammation, and clinical status in patients with primary sepsis: Study protocol and review on previous studies

Naseh Pahlavani, Alireza Sedaghat, Ahmad Bagheri Moghaddam et al. · Clinical Nutrition ESPEN · 2019 · 41 citations

Inflammation, Clinical Status, Sepsis +6

Challenges and Barriers to Providing Care to Older Adult Patients in the Intensive Care Unit: A Qualitative Research

Abbas Heydari, Mohammadhesam Sharifi, Ahmad Bagheri Moghaddam · Open Access Macedonian Journal of Medical Sciences · 2019 · 36 citations · Full text